Selective estrogen receptor modulators prevent neointima formation after vascular injury
- 1 November 2004
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 227 (1-2) , 9-20
- https://doi.org/10.1016/j.mce.2004.08.004
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Raloxifene inhibits cholesterol aortic content but not atherosclerotic plaque size in oophorectomised cholesterol-fed rabbitsJournal of Obstetrics and Gynaecology, 2004
- Opposite effects of testosterone and estrogens on chronic allograft nephropathyTransplant International, 2002
- Elimination of vascular fibrointimal hyperplasia bysomatostatin receptor 1.4 selective agonistThe FASEB Journal, 2002
- Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal WomenJAMA, 2002
- 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γProceedings of the National Academy of Sciences, 2001
- Estrogen-Induced Vasoprotection Is Estrogen Receptor DependentCirculation, 2000
- Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCRGene, 1999
- Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal MonkeysJournal of Clinical Endocrinology & Metabolism, 1998
- Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed RabbitsCirculation, 1997
- Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation.Circulation Research, 1990